AboutContact usRSS
dotsbydots
SEARCHCONTACT US

Buzz

Most popular

Daily
Weekly
1
The 83-year-old who sold his invention for $466 million, and still walks to work every morning
2
Serbia revealed as buyer in Elbit’s $1.63 billion arms deal
3
“Startups in Portugal and Israel are in a similar situation because the local market is not big enough”
4
AppsFlyer in advanced talks to be acquired at over $3.5 billion valuation
5
Why did a U.S. court let an Israeli cyber executive accused of pedophilia walk free on $10,000 bail?
More news

Multiple Sclerosis

2 stories about Multiple Sclerosis
ה מטה הנוכחי של טבע ב ארה"ב

Mylan Cuts Price of Generic Copaxone Offering by 60%

11.07.18|Lilach Baumer
Mylan has achieved a 15%-20% market share in the U.S. since launching its generic version in late 2017 with a monthly price tag of $5,000, compared to Teva's $5,800
default image

Former Teva Executive One Step Closer to Bringing Copaxone Rival to Market

31.10.17|Lilach Baumer
Mapi Pharma announced a successful phase II clinical trial for its Copaxone equivalent GA Depot